Navigation Links
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Date:1/26/2009

ABBOTT PARK, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Data published online today in Circulation from the SPIRIT III U.S. pivotal trial evaluating the XIENCE V(TM) Everolimus Eluting Coronary Stent System demonstrated that Abbott's market-leading XIENCE V outperforms the TAXUS(R) Express2(TM) Paclitaxel-Eluting Coronary Stent System (TAXUS) in reducing major adverse cardiac events (MACE) at two years. In the SPIRIT III trial of 1,002 patients, XIENCE V demonstrated a 45 percent reduction in the risk of MACE, and a 40 percent reduction in the risk of cardiac death or heart attack (myocardial infarction, or MI) at two years in patients treated with XIENCE V compared to those treated with TAXUS. Additionally, at two years the study demonstrated a 32 percent reduction in the risk of target vessel failure (TVF, cardiac events related to the treated vessel) for XIENCE V compared to TAXUS. These published results were first presented in May 2008 at the EuroPCR Congress in Barcelona.

"As published in Circulation, the SPIRIT III study results demonstrate that the clinical benefits of XIENCE V continue to improve between one and two years of follow-up after stent implantation compared to TAXUS," said Gregg W. Stone, M.D., Columbia University Medical Center; chairman, Cardiovascular Research Foundation, New York; and principal investigator of the SPIRIT III trial. "These data reinforce our earlier findings demonstrating the excellent angiographic and clinical results with the XIENCE V stent, resulting in fewer heart attacks and repeat reinterventions."

The SPIRIT III trial demonstrated the following key results for XIENCE V at two years:

-- A 45 percent reduction in the risk of MACE compared to TAXUS (7.3 percent for XIENCE V vs. 12.8 percent for TAXUS, p-value=0.004)*. MACE is an important composite clinical measure of safety and effic
'/>"/>

SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
2. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
5. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
6. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
7. Franklin & Seidelmann Publishes Complex Podiatry MRI Study
8. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
9. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
10. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
11. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... SAN DIEGO , July 29, 2015  ViaCyte, Inc., a ... therapy for the treatment of diabetes in clinical trials, today announced ... called STEP ONE, or S afety, T olerability, and ... One Diabetes.  The new site, which is the first ... of Alberta Hospitals in Edmonton , Alberta.  ...
(Date:7/29/2015)... July 27, 2015 Research ... the "Pharmaceutical Packaging Market by Packaging Type, by ... Europe, Asia-Pacific, RoW) - Forecasts to 2020" report ... market demand, by value is estimated to reach above ... market is anticipated to show a steady growth rate ...
(Date:7/29/2015)... , July 29, 2015 KaloBios Pharmaceuticals, ... focused on developing innovative therapies to benefit patients with ... oncology, announced today that it received a formal determination ... the company that it is now compliant with the ... NASDAQ Global Market and is no longer subject to ...
Breaking Medicine Technology:ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 2KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 3KaloBios Regains Compliance with NASDAQ Minimum Bid Price Requirement 4
... CYBX ) today announced that Dan Moore, President and ... present at the 22nd Annual Piper Jaffray Health Care Conference ... PM ET.  The conference session and webcast will be audio ... will host a webcast of the presentation live and by ...
... Patients with Chronic Obstructive Pulmonary Disease, or COPD, ... burden they must deal with and as a loss ... by GlaxoSmithKline.  Patients participating in the research characterized their ... loss of energy, loss of control, loss of independence ...
Cached Medicine Technology:Cyberonics to Present at 22nd Annual Piper Jaffray Health Care Conference 2COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 2COPD Patients Reveal Disease Progression Leads to Physical and Social Isolation and Increased Reliance on the Internet(1) 3
(Date:7/29/2015)... ... 29, 2015 , ... A June 10, 2015 article from the News-Press, entitled ... importance of having regular skin cancer screenings from an early age. Skin cancer can ... When caught early, skin cancer is rarely fatal; however, if left alone for too ...
(Date:7/29/2015)... ... ... Several years ago, in order to be in the strongest position possible ... stance and began planning the Children’s Village consisting of six homes. , Two are ... third home. , “We are very pleased to have received the $500,000 grant from ...
(Date:7/29/2015)... Toronto, Canada (PRWEB) , ... July 29, 2015 ... ... described as a “forward thinker.” Since the late 1970s, Dr. Cottrell has been ... His new book, The New Earth, documents many of these prognostications. He warns ...
(Date:7/29/2015)... ... 29, 2015 , ... National non-profit World T.E.A.M. Sports announced ... employee benefits and asset management, has joined as presenting sponsor for the inaugural ... Charlotte, North Carolina on October 2-4, 2015. , Hosted at the U.S. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... illnesses is seeking funding for a study on the potentially lifesaving impact of ... Institute today . , The research proposal is based on a successful ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... January 2006 issue of AGD Impact, the newsmagazine of ... are the best way to correct crooked teeth. Orthodontics, ... is a great help in improving the "stability, function, ... can make people feel better about themselves,” said AGD ...
... March/April 2005 issue of General Dentistry, the Academy of General ... a unique position to diagnose and treat oral reactions, associated ... ,Scott S. DeRossi, DMD, the lead ... some sort of a reaction and the mouth is the ...
... city, talking the toll to three, as more than 200 ... disease.// ,"A 24-year-old man from the Khetwadi area of ... general of health services T.P. Doke told IANS. ... city - mostly in south Mumbai - affected by gastroenteritis. ...
... Now there is an answer, not to far, to the ... to researchers at the University of Calgary whose bioengineering team ... cells in their laboratory. ,In the words ... the path to effectively producing human tissue that may be ...
... Khan has come together to shoot an advertisement// that will ... the recent bird flu scare. ,"This bird flu scare ... Sanju, Suniel and Fardeen believe chicken well cooked is harm ... ,"I believe chicken is the only source of real ...
... week’s edition of BMJ, parents who have taken care of ... depressed after the child’s death that there is every chance ... consuming overdoses of potent painkillers, used to alleviate the child’s ... there is very little research on the suicide rates of ...
Cached Medicine News:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: